Robert Stone

Robert Stone

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
View Bio
RSS

Latest Posts › SAMHSA

Share:

Health Care Week in Review: Members of Congress Introduce Bipartisan, Bicameral PBM Reform Bill; ASTP/ONC Releases TEFCA Final...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/18/2024  /  AHRQ , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , Health Insurance , Healthcare , Pharmacy Benefit Manager (PBM) , Public Health , SAMHSA

Health Care Week in Review: Biden Administration Submits Disaster Aid Request; Senators Propose New Health Care Cybersecurity...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

11/25/2024  /  Biden Administration , Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Cybersecurity , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare , HRSA , Medicaid , Medicare , National Institute of Health (NIH) , Prescription Drugs , SAMHSA

Health Care Week in Review: Texas Judge Blocked FTC Rule Banning Noncompetes; Biden Administration Announced $1.4 Billion for HIV...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/26/2024  /  Abbreviated New Drug Application (ANDA) , Centers for Disease Control and Prevention (CDC) , Drug Pricing , Federal Trade Commission (FTC) , Food and Drug Administration (FDA) , Generic Drugs , Health Care Providers , Healthcare , Healthcare Facilities , HIV , HRSA , Medical Devices , Mental Health , Pharmaceutical Industry , Prescription Drugs , Public Health Service (PHS) , SAMHSA , Vaccinations

Health Care Week in Review: CMS Finalizes FY 2025 Payment Rules for Inpatient Hospitals, Inpatient Rehab Facilities, Inpatient...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/5/2024  /  Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , Food Safety , Generic Drugs , Health Care Providers , Healthcare , Healthcare Facilities , Hospice , Hospitals , Inpatient Rehab Facilities , Long Term Care Facilities , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , Prescription Drugs , Psychiatric Hospitals , SAMHSA , Skilled Nursing Facility

Health Care Week in Review: CMS Releases Final Medicare Prescription Payment Plan Part 2 Guidance

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/22/2024  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance , Healthcare , Healthcare Facilities , Medicaid , Medicare , Pharmaceutical Industry , Physicians , Prescription Drugs , SAMHSA

Health Care Week in Review: House Members Introduced Legislation Intended to Enhance 340 Program Transparency; HHS Released...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/3/2024  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , SAMHSA , Section 340B

Health Care Week in Review: House Held a Markup of Telehealth Legislation; CMS Introduced a New Model to Improve the Kidney...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/13/2024  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , HRSA , Medicaid , Medical Devices , Medicare , National Institute of Health (NIH) , Organ Transplant Centers , Prescription Drugs , SAMHSA , Telehealth

Health Care Week in Review: HHS Finalizes Rule Prohibiting Disability Discrimination; FDA Finalizes LDT Rule; Senate Finance...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/6/2024  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Disability Discrimination , Drug Pricing , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Health Care Providers , Life Sciences , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , Prescription Drugs , SAMHSA

Health Care Week in Review: House Passes Appropriations Bill and Senate Expected to Vote Shortly, CMS Unveils the ACO Primary Care...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/25/2024  /  Biologics , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance , HRSA , Medicare , Mental Health , Pharmaceutical Industry , Prescription Drugs , Public Health , SAMHSA

Health Care Week in Review: Congress Passed a New Continuing Resolution for FY 2024 to Avert a Government Shutdown; Biden...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/4/2024  /  21st Century Cures Act , Biologics , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Child Care , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , Prescription Drugs , SAMHSA

Health Care Week In Review: CMS Releases Guidance on Medicare Prescription Payment Plan and House Holds a Hearing on 19 Health...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/19/2024  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , HRSA , Investigational New Drug Application (IND) , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , SAMHSA

Health Care Week in Review: HHS Releases Conscience Rights Final Rule; Biden Administration Announces ARPA-H Program to Invest in...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

1/15/2024  /  Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Mental Health , National Institute of Health (NIH) , Popular , SAMHSA

Health Care Week In Review: HRSA Releases List of Health Professional Shortage Areas, Biden Bolsters HHS Authority to Address Drug...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

1/8/2024  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Life Sciences , Medicaid , Medicare , National Institute of Health (NIH) , Prescription Drugs , SAMHSA

Health Care Week in Review: House E&C Subcommittee on Health Held a Hearing on Healthcare and AI; CMS Extended the Application...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/4/2023  /  Artificial Intelligence , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare , Life Sciences , Medical Devices , OIG , Popular , SAMHSA

Health Care Week In Review: Senate Finance Committee Advanced Bipartisan Healthcare Legislation, CMS Released Medicare Advantage...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

11/13/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Hospitals , Medicare , Medicare Advantage , Medicare Part D , Mental Health , Pharmaceutical Industry , Popular , Prescription Drugs , SAMHSA

Health Care Week in Review: CMS Issues Final Rule on Medicare Savings Program, Senate Considers Primary Care and Healthcare...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/25/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Workers , HRSA , Medicare , Prescription Drugs , SAMHSA

Health Care Week in Review: PAHPA Reauthorization Bills Receive House and Senate Markups

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/24/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Workers , Infectious Diseases , Medicaid , Medicare , Mental Health , OIG , Popular , SAMHSA , Substance Abuse

Health Care Week in Review: Emerging Technology Coverage Pathway, Long COVID Advisory

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/26/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , SAMHSA

Health Care Week in Review: Congress Raises Debt Ceiling, CMS Issues Final Rule

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/5/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Long Term Care Facilities , Long-Term Care , Medicaid , Medicare , National Institute of Health (NIH) , Popular , SAMHSA

Health Care Week In Review: CMS Issues Proposed Rule, CBO Releases Health Insurance Coverage Projections

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/30/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Insurance , Medicaid , Medicare , National Institute of Health (NIH) , OIG , SAMHSA

Health Care Week In Review: Surgeon General Advisory on Loneliness and EMTALA Requirements

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/8/2023  /  Biosimilars , Centers for Disease Control and Prevention (CDC) , Clinical Trials , Department of Health and Human Services (HHS) , EMTALA , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medical Devices , National Institute of Health (NIH) , Popular , SAMHSA

Health Care Week In Review: HHS Final Rule and President Biden Executive Order

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

4/24/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Mental Health , National Institute of Health (NIH) , Popular , Reproductive Healthcare Issues , SAMHSA

Health Care Week in Review: CMS Issues Proposed and Final Rules and NIH Releases a Cancer Plan

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

4/10/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , National Institute of Health (NIH) , SAMHSA

Health Care Week in Review: Health Care Budget Hearings and Organ System Modernization

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/27/2023  /  Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medicare , SAMHSA

Health Care Week in Review: FY 2024 Appropriations Process Begins

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/27/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medicaid , Medicare , National Institute of Health (NIH) , SAMHSA
25 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide